Clinic
HG Pediatrics, PLLC
HG Pediatrics, PLLC was paid $6.85M by Medicaid between Jan 2018 and Dec 2024, across 79 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 26% of everything it billed.
33Billing provider infoHG PEDIATRICS, PLLC
HOUSTON, TX 77008
HOUSTON, TX 77008
33aNPI1568816726assigned 04/14/2016
33bProvider typeMedical Specialty Clinic/Center
28Total paid$6.85M
24GClaims252,725
24DCodes billed79
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Medical Specialty Clinic/Center providers in Texas
Rank by total paid#1 of 31
Median peer was paid$16K
This provider vs. median441×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 694 | $43K | |
| 2019 | 2,642 | $77K | |
| 2020 | 13,290 | $342K | |
| 2021 | 51,331 | $1.19M | |
| 2022 | 65,783 | $1.77M | |
| 2023 | 67,789 | $1.81M | |
| 2024incomplete | 51,196 | $1.62M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 26% | 45,912 | 34,755 | $1.79M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 15% | 12,809 | 11,157 | $1.02M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 11% | 8,928 | 8,874 | $749K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 8.6% | 7,153 | 6,864 | $590K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 6.8% | 8,963 | 8,508 | $464K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 6.5% | 38,317 | 15,925 | $442K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.6% | 2,750 | 2,728 | $247K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.2% | 4,001 | 3,842 | $222K |
| S8301 | Infection control supplies, not otherwise specified | 2.4% | 18,127 | 14,920 | $166K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.2% | 4,920 | 4,724 | $150K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.9% | 17,809 | 17,267 | $129K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.8% | 1,280 | 1,264 | $124K |
67 more codes
| 99239 | Hospital discharge day management, more than 30 minutes | 1.8% | 1,608 | $122K |
| 99460 | 1.8% | 1,625 | $122K | |
| 87634 | 1.5% | 1,708 | $101K | |
| 99203 | Doctor's office visit, new patient (routine) | 1.3% | 1,398 | $86K |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 1.1% | 15,359 | $73K |
| 99381 | 1.0% | 889 | $71K | |
| 99462 | <1% | 999 | $37K | |
| 90461 | <1% | 4,560 | $35K | |
| 99383 | <1% | 258 | $25K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 898 | $24K |
| 36406 | <1% | 1,479 | $20K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 727 | $9K |
| 99382 | <1% | 65 | $6K | |
| 0081A | <1% | 86 | $3K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 247 | $3K |
| 0072A | <1% | 67 | $3K | |
| 81002 | <1% | 874 | $3K | |
| 0001A | <1% | 64 | $2K | |
| 0071A | <1% | 49 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 136 | $2K |
| 99384 | <1% | 17 | $2K | |
| 96160 | <1% | 3,424 | $1K | |
| 96381 | <1% | 66 | $1K | |
| 0082A | <1% | 21 | $818.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 64 | $730.41 |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 12 | $571.79 |
| 97802 | <1% | 47 | $181.60 | |
| 81001 | <1% | 15 | $48.60 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 247 | $8.33 |
| 90671 | <1% | 1,521 | $4.68 | |
| 90677 | <1% | 582 | $4.01 | |
| 90697 | <1% | 918 | $1.52 | |
| 90686 | <1% | 1,800 | $0.94 | |
| 91307 | <1% | 185 | $0.44 | |
| 91308 | <1% | 184 | $0.29 | |
| 90651 | <1% | 555 | $0.24 | |
| 90380 | <1% | 71 | $0.10 | |
| 90619 | <1% | 61 | $0.10 | |
| 90658 | <1% | 985 | $0.09 | |
| 90381 | <1% | 74 | $0.06 | |
| 91300 | <1% | 88 | $0.05 | |
| 90620 | <1% | 82 | $0.05 | |
| 90656 | <1% | 262 | $0.04 | |
| 90707 | <1% | 2,245 | $0.02 | |
| 90700 | <1% | 1,433 | $0.01 | |
| 90734 | <1% | 229 | $0.01 | |
| 90633 | <1% | 3,228 | $0.01 | |
| 90670 | <1% | 4,728 | $0.01 | |
| 90681 | <1% | 216 | $0.01 | |
| 90744 | <1% | 2,541 | $0.01 | |
| 90716 | <1% | 2,254 | $0.01 | |
| 90715 | 0% | 49 | $0.00 | |
| 99173 | 0% | 5,327 | $0.00 | |
| 90710 | 0% | 352 | $0.00 | |
| 90649 | 0% | 26 | $0.00 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 0% | 46 | $0.00 |
| 90648 | 0% | 18 | $0.00 | |
| 94664 | 0% | 19 | $0.00 | |
| 90655 | 0% | 50 | $0.00 | |
| S3620 | Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) | 0% | 383 | $0.00 |
| 90680 | 0% | 4,951 | $0.00 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 0% | 2,371 | $0.00 |
| 90647 | 0% | 1,369 | $0.00 | |
| 90696 | 0% | 905 | $0.00 | |
| 90698 | 0% | 4,490 | $0.00 | |
| 96127 | 0% | 136 | $0.00 | |
| 90688 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGARZA, HOMERO (OWNER)